Literature DB >> 12523594

Delay of diagnosis in pancreatic cancer due to suspected symptomatic cholelithiasis.

B M Ghadimi1, O Horstmann, K Jacobsen, J Feth, H Becker.   

Abstract

BACKGROUND: A single centre study was conducted to examine the frequency of cholecystectomies, both open and laparoscopic, up to 2 years prior to the diagnosis of pancreatic cancer. In particular, it was of interest to investigate whether there is a diagnostic delay in a significant number of pancreatic cancer patients and if these patients already have symptoms or findings at the time of cholecystectomy that might have been indicative of the underlying malignant disease.
METHODS: It is demonstrated that 17 out of 186 pancreatic cancer patients (9%) underwent a cholecystectomy within the 2 years prior to cancer diagnosis.
RESULTS: A significant number of these patients showed a considerable weight loss at the time of the cholecystectomy. It is hypothesized that symptoms which led to cholecystectomies in these patients were most likely related to the pancreatic cancer. Owing to the resulting delay of pancreatic cancer diagnosis the resection rate with curative intent decreases to 35% from 44% in the whole series.
CONCLUSION: Patients suffering from cholecystolithiasis and showing atypical symptoms or other notable findings such as considerable weight loss might be assessed in more detail pre- as well as postoperatively in order to minimize the diagnostic delay in pancreatic cancer and to avoid unnecessary operations.

Entities:  

Mesh:

Year:  2002        PMID: 12523594     DOI: 10.1080/003655202762671323

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation.

Authors:  Douglas S Swords; Mary C Mone; Chong Zhang; Angela P Presson; Sean J Mulvihill; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

2.  Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.

Authors:  Feriel Sellam; Noria Harir; Méghit B Khaled; Nesrine M Mrabent; Rachida Salah; Mustapha Diaf
Journal:  J Gastrointest Cancer       Date:  2015-06

3.  "It can't be very important because it comes and goes"--patients' accounts of intermittent symptoms preceding a pancreatic cancer diagnosis: a qualitative study.

Authors:  Julie Evans; Alison Chapple; Helen Salisbury; Pippa Corrie; Sue Ziebland
Journal:  BMJ Open       Date:  2014-02-18       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.